Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Devic's Syndrome Treatment Market by Treatment (Corticosteroids, Immunosuppressants, Plasma Exchange (Plasmapheresis)), Distribution Channel (Clinics, Hospitals, Online Pharmacies), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 220.27 million in 2024, at a CAGR 4.68% to reach USD 290.03 million by 2030. Devic's Syndrome, also known as neuromyelitis optica (NMO), is a chronic disorder of ... Read More
-
Infertility Drugs & Devices Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. High cost of treatment A single ... Read More
-
RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Market Growth & Trends The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new ... Read More
-
Pulmonary Drugs Market by Drug Class (Anti-Cholinergic Agents, Anti-Leukotrienes, Antihistamines), Indication (Allergic Rhinitis, Asthma, Chronic Obstructive Pulmonary Disease), Drug Type, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 79.35 billion in 2023 and expected to reach USD 86.14 billion in 2024, at a CAGR 8.03% to reach USD 136.27 billion by 2030. The pulmonary drugs market encompasses a wide range of therapeutic ... Read More
-
COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Global Forecast 2024-2030
... to reach USD 6.79 billion in 2024, at a CAGR 13.93% to reach USD 14.84 billion by 2030. The COVID-19 clinical trials market comprises all research activities and trials to examine the efficacy and safety ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological treatments ... Read More
-
Tumor Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Tumor Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others), By Technology (Microarray, Real-Time Quantitative, Polymerase Chain Reaction (Q-PCR), Others), By Product (Consumables, Instrument, Software & Services), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others), and By Region, 2019-2029F
... Others), By Product (Consumables, Instrument, Software & Services), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others), and By Region, 2019-2029F Global Tumor ... Read More
-
Vietnam Tuberculosis Therapeutics Market, By Disease Type (Active Tuberculosis and Latent Tuberculosis), By Therapy (First Line Therapy and Second Line Therapy), By Region, Competition, Forecast and Opportunities, 2019-2029F
... USD 25.48 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.12% through 2029. The Vietnam Tuberculosis Therapeutics Market is primarily driven by several key factors ... Read More
-
Amyotrophic Lateral Sclerosis- Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Acid sphingomyelinase deficiency (ASMD) – Market Insight, Epidemiology, and Market Forecast – 2034
... sphingomyelinase deficiency (ASMD), historical and forecasted epidemiology as well as the Acid sphingomyelinase deficiency (ASMD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acid sphingomyelinase deficiency ... Read More
-
Adamantinoma – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Adamantinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Adamantinoma market report provides current treatment practices, emerging drugs, Adamantinoma market share of the individual ... Read More
-
Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis, historical and forecasted epidemiology as well as the Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis market trends in the United States, EU5 (Germany, ... Read More
-
Allergic Bronchopulmonary Aspergillosis – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Allergic Bronchopulmonary Aspergillosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Allergic Bronchopulmonary Aspergillosis market report provides current ... Read More
-
Ataxia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Ataxia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Ataxia market report provides current treatment practices, emerging drugs, Ataxia market share of the individual ... Read More
-
Attention-deficit/hyperactivity disorder (ADHD) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Attention-deficit/hyperactivity disorder (ADHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Attention-deficit/hyperactivity disorder (ADHD) market report provides current ... Read More
-
Autoimmune Hepatitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune Hepatitis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Bladder cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Bladder cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Bladder cancer market report provides current treatment practices, emerging drugs, Bladder ... Read More
-
Acquired Blepharoptosis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Acquired Blepharoptosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acquired Blepharoptosis market report provides current treatment practices, emerging drugs, Acquired ... Read More
-
Adenosine Deaminase-Severe Combined Immunodeficiency – Market Insight, Epidemiology, and Market Forecast – 2034
... Deaminase-Severe Combined Immunodeficiency, historical and forecasted epidemiology as well as the Adenosine Deaminase-Severe Combined Immunodeficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Adenosine Deaminase-Severe Combined ... Read More
-
Anaplastic Astrocytoma – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Anaplastic Astrocytoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Anaplastic Astrocytoma market report provides current treatment practices, emerging drugs, Anaplastic ... Read More
-
Aneurysmal Subarachnoid Hemorrhage (SAH) – Market Insight, Epidemiology, and Market Forecast – 2034
... Subarachnoid Hemorrhage (SAH), historical and forecasted epidemiology as well as the Aneurysmal Subarachnoid Hemorrhage (SAH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Aneurysmal Subarachnoid Hemorrhage ... Read More
-
Arteriovenous fistula – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Arteriovenous fistula market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Arteriovenous fistula market report provides current treatment practices, emerging drugs, Arteriovenous ... Read More
-
Menorrhalgia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Menorrhalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Menorrhalgia market report provides current treatment practices, emerging drugs, Menorrhalgia market share of the individual ... Read More
-
DDR Defective Tumors – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the DDR Defective Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The DDR Defective Tumors market report provides current ... Read More
-
Dense Deposit Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Dense Deposit Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dense Deposit Disease market report provides current ... Read More
Research Assistance
